Latest News & Features
Careers
Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises. 29 January 2026
Americas
A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates and patent abuse to extend its insulin monopoly, though one allegation was dismissed. 29 January 2026
Careers
New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation capabilities. 29 January 2026
Americas
The rise of fake online stores selling counterfeit pharmaceuticals is driving a surge in domain name disputes, forcing major brands to defend revenue and reputation. 28 January 2026
Americas
As quantum-enabled innovation accelerates, patentability will hinge on predictability, disclosure, and modality-specific claim drafting in an increasingly unforgiving enablement landscape, explain Ray Miller and Joseph Wolfe of DLA Piper 27 January 2026
Americas
The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent. 26 January 2026
Careers
The new recruit has a “stellar track record” of representing big tech in trade secret and patent litigation, and joins the firm’s newly opened San Francisco office. 26 January 2026
Americas
Just one pharma company is recognised in a report that lists the most world's most inventive countries and companies. 23 January 2026
Americas
A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent. 22 January 2026
Americas
New rankings from LSIPR’s sister title spotlight the firms and lawyers that are most successfully navigating the volatile world of trade secrets, from ‘prompt injections’ to billion-dollar retrials. 22 January 2026